Showing results (361-370 of 6,931) with videos related to
Sort By:
Pageof 694
Annals of Translational Medicine|June 23, 2020
Circulating CX3CR1+CD163+ M2 monocytes markedly elevated and correlated with cardiac markers in patients with acute myocardial infarctionXia Shao, Boting Wu, Pu Chen, et al.Annals of Translational Medicine|June 23, 2020
A deep learning, image based approach for automated diagnosis for inflammatory skin diseasesHaijing Wu, Heng Yin, Haipeng Chen, et al.Annals of Translational Medicine|June 23, 2020
Expression of a novel immune checkpoint B7-H6 ligand in human small cell lung cancerXiuqin Zhang, Weiguo Xie, Zhiqiang Wang, et al.Annals of Translational Medicine|June 23, 2020
FOXP3 promotes colorectal carcinoma liver metastases by evaluating MMP9 expression via regulating S-adenosylmethionine metabolismZhe Wang, Jingdong ZhangAnnals of Translational Medicine|June 23, 2020
Quantitative analysis of chest CT imaging findings with the risk of ARDS in COVID-19 patients: a preliminary studyYi Wang, Yuntian Chen, Yi Wei, et al.Annals of Translational Medicine|June 23, 2020
Net benefit of routine urine parameters for urinary tract infection screening: a decision curve analysisYan-Qiu Han, Lei Zhang, Jun-Rui Wang, et al.Annals of Translational Medicine|June 23, 2020
Matrix-assisted laser desorption ionization time-of-flight mass spectrometry combined with UF-5000i urine flow cytometry to directly identify pathogens in clinical urine specimens within 1 hourChuang Sun, Xiao Zhang, Jingqiao Wang, et al.Annals of Translational Medicine|June 23, 2020
A hook-effect-free homogeneous light-initiated chemiluminescence assay: is it reliable for screening and the quantification of the hepatitis B surface antigen?Ruifeng Yang, Liyan Cui, Yan Liu, et al.Annals of Translational Medicine|September 17, 2021
Identification of diagnostic and prognostic signatures derived from preoperative blood parameters for oral squamous cell carcinomaXiang Wu, Yuan Yao, Yibin Dai, et al.Annals of Translational Medicine|September 17, 2021
Survival benefit of immune checkpoint inhibitor monotherapy in patients with non-small cell lung cancer recurrence after completely pulmonary resectionHiroaki Kuroda, Yusuke Takahashi, Suguru Shirai, et al.Pageof 694